GLP1R and type 2 diabetes mellitus: A further approved type 2 diabetes GLP‐1 mimetic peptide, lixisenatide, shares the first 37 amino acids with exendin‐4, including most of the GAPPPS sequence but includes an additional six lysine residues at the C‐terminus prior to the terminal amidation (Andersen et al., 2018).